 |
Journal articles
A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells.
Abstract : BACKGROUND: The development of effective cancer vaccines still remains a challenge. Despite the crucial role of plasmacytoid dendritic cells (pDCs) in anti-tumor responses, their therapeutic potential has not yet been worked out. We explored the relevance of HLA-A*0201 matched allogeneic pDCs as vectors for immunotherapy. METHODS AND FINDINGS: Stimulation of PBMC from HLA-A*0201(+) donors by HLA-A*0201 matched allogeneic pDCs pulsed with tumor-derived peptides triggered high levels of antigen-specific and functional cytotoxic T cell responses (up to 98% tetramer(+) CD8 T cells). The pDC vaccine demonstrated strong anti-tumor therapeutic in vivo efficacy as shown by the inhibition of tumor growth in a humanized mouse model. It also elicited highly functional tumor-specific T cells ex-vivo from PBMC and TIL of stage I-IV melanoma patients. Responses against MelA, GP100, tyrosinase and MAGE-3 antigens reached tetramer levels up to 62%, 24%, 85% and 4.3% respectively. pDC vaccine-primed T cells specifically killed patients' own autologous melanoma tumor cells. This semi-allogeneic pDC vaccine was more effective than conventional myeloid DC-based vaccines. Furthermore, the pDC vaccine design endows it with a strong potential for clinical application in cancer treatment. CONCLUSIONS: These findings highlight HLA-A*0201 matched allogeneic pDCs as potent inducers of tumor immunity and provide a promising immunotherapeutic strategy to fight cancer.
https://www.hal.inserm.fr/inserm-00484505
Contributor : Laurence Chaperot <>
Submitted on : Tuesday, May 18, 2010 - 3:13:29 PM
Last modification on : Friday, November 6, 2020 - 3:46:53 AM
Long-term archiving on: : Thursday, September 16, 2010 - 2:06:24 PM
Contributor : Laurence Chaperot <>
Submitted on : Tuesday, May 18, 2010 - 3:13:29 PM
Last modification on : Friday, November 6, 2020 - 3:46:53 AM
Long-term archiving on: : Thursday, September 16, 2010 - 2:06:24 PM
Files
Aspord_-_PLoS_One_supplementar...
Publisher files allowed on an open archive
- Aspord_et_al_PLoS_One_2010.pdf Publisher files allowed on an open archive